Canlyniadau Chwilio

Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling gan Flore Kruiswijk, Sebastian C. Hasenfuss, Renuka Sivapatham, Marjolein P. Baar, Diana A. Putavet, Kishan A.T. Naipal, Niels J. F. van den Broek, Wim H.J. Kruit, Peter J. van der Spek, Dik C. van Gent, Arjan B. Brenkman, Judith Campisi, Boudewijn Burgering, Jan H.J. Hoeijmakers, Peter L.J. de Keizer

Cael y testun llawn Cael y testun llawn

Identification of MET and SRC Activation in Melanoma Cell Lines Showing Primary Resistance to PLX4032 gan Elisabetta Vergani, Viviana Vallacchi, Simona Frigerio, Paola Deho, Piera Mondellini, Paola Perego, Giuliana Cassinelli, Cinzia Lanzi, M. Testi, Licia Rivoltini, Italia Bongarzone, Monica Rodolfo

Cael y testun llawn

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia gan Enrico Tiacci, Jae H. Park, Luca De Carolis, Stephen S. Chung, Alessandro Broccoli, Sasinya N. Scott, Francesco Zaja, Sean M. Devlin, Alessandro Pulsoni, Young Rock Chung, Michele Cimminiello, Eun Hee Kim, Davide Rossi, Richard M. Stone, Giovanna Motta, Alan Saven, Marzia Varettoni, Jessica K. Altman, Antonella Anastasia, M. R. Grever, Achille Ambrosetti, R. Kanti, Vincenzo Fraticelli, Mario E. Lacouture, Angelo Michele Carella, Ross L. Levine, Pietro Leoni, Alessandro Rambaldi, Franca Falzetti, Stefano Ascani, Monia Capponi, Maria Paola Martelli, Christopher Y. Park, Stefano Pileri, Neal Rosen, Robin Foà, Michael F. Berger, Pier Luigi Zinzani, Omar Abdel‐Wahab, Brunangelo Falini, Martin S. Tallman

Cael y testun llawn Cael y testun llawn

Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma gan Francesco Spagnolo, Paola Ghiorzo, Paola Queirolo

Cael y testun llawn Cael y testun llawn

Inhibitors of pan-PI3K Signaling Synergize with BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth gan Melanie Sweetlove, Emma Wrightson, Sharada Kolekar, Gordon W. Rewcastle, Bruce C. Baguley, Peter R. Shepherd, Stephen M. F. Jamieson

Cael y testun llawn Cael y testun llawn

Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma gan Georgina V. Long, Victoria Atkinson, Paolo A. Ascierto, Benjamin Brady, Caroline Dutriaux, Michele Maio, Laurent Mortier, Jessica C. Hassel, Piotr Rutkowski, Catriona M. McNeil, Ewa Kalinka‐Warzocha, Kerry J. Savage, Micaela Hernberg, Célèste Lebbé, J. Charles, Catalin Mihalcioiu, Vanna Chiarion‐Sileni, Cornelia Mauch, Henrik Schmidt, Dirk Schadendorf, Helen Gogas, Christine E. Horak, Brian J. Sharkey, Ian M. Waxman, Caroline Robert

Cael y testun llawn Cael y testun llawn

Pruritus to anticancer agents targeting the EGFR, BRAF, and CTLA-4 gan Alyssa Fischer, Alyx Rosen, Courtney J. Ensslin, Shenhong Wu, Mario E. Lacouture

Cael y testun llawn

Mitochondrial oxidative stress is the achille's heel of melanoma cells resistant to Braf-mutant inhibitor gan Paola Corazao-Rozas, P. Guerreschi, Manel Jendoubi, Fanny André, Aurélie Jonneaux, C. Scalbert, Guillaume Garçon, Myriam Malet‐Martino, Stéphane Balayssac, Stéphane Rocchi, Ariel Savina, Pierre Formstecher, Laurent Mortier, Jérôme Kluza, Philippe Marchetti

Cael y testun llawn Cael y testun llawn

Dormancy of metastatic melanoma gan Liliana Ossowski, Julio A. Aguirre‐Ghiso

Cael y testun llawn Cael y testun llawn

Long-term outcome in BRAFV600E melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progression gan Igor Puzanov, Ravi K. Amaravadi, Grant A. McArthur, Keith T. Flaherty, Paul B. Chapman, Jeffrey A. Sosman, Antoni Ribas, Mark Shackleton, Patrick Hwu, Bartosz Chmielowski, K. B. Nolop, Paul Lin, Kevin B. Kim

Cael y testun llawn

Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: a case report gan Dae Won Kim, Edelyn Barcena, Urvi Mehta, Michelle Rohlfs, Ashok Kumar, Marta Penas‐Prado, Kevin B. Kim

Cael y testun llawn Cael y testun llawn

Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma gan Aoxue Wang, Xiaoyi Qi

Cael y testun llawn Cael y testun llawn

Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation gan Rita E Morales, Alexander N. Shoushtari, Michelle M. Walsh, Priya Grewal, Evan J. Lipson, Richard D. Carvajal

Cael y testun llawn Cael y testun llawn

Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma gan François‐Clément Bidard, Jordan Madic, Pascale Mariani, Sophie Piperno‐Neumann, Aurore Rampanou, Vincent Servois, Nathalie Cassoux, Laurence Desjardins, Maud Milder, Isabelle Vaucher, Jean‐Yves Pierga, Ronald Lebofsky, Marc‐Henri Stern, Olivier Lantz

Cael y testun llawn

Intra- and Inter-Tumoral Homogeneity of BRAF V600E Mutations in Melanoma Tumors gan Erica Riveiro‐Falkenbach, Cándida A. Villanueva, María C. Garrido, Yolanda Ruano, Rosa García-Martín, Elena Godoy, Pablo L. Ortiz‐Romero, J.J. Ríos-Martín, Ángel Santos‐Briz, José Luis Rodríguez‐­Peralto

Cael y testun llawn Cael y testun llawn

Recent developments in the medical and surgical treatment of melanoma gan Vita Saranga‐Perry, Chenwi M. Ambe, Jonathan S. Zager, Ragini R. Kudchadkar

Cael y testun llawn Cael y testun llawn

The KISS1 metastasis suppressor: mechanistic insights and clinical utility gan T. Nash Kevin

Cael y testun llawn Cael y testun llawn

Targeting Oncogenic BRAF in Human Cancer gan Christine A. Pratilas, Feng Xing, David B. Solit

Cael y testun llawn

Antigenic heterogeneity of surgically removed primary and autologous metastatic human melanoma lesions. gan Pier Giorgio Natali, R. Cavaliere, A Bigotti, M. Nicotra, C. Russo, Ah Kau Ng, Patrizio Giacomini, Soldano Ferrone

Cael y testun llawn Cael y testun llawn

Transmission of Donor Melanoma to Multiple Organ Transplant Recipients gan Gareth Morris‐Stiff, Andrew Steel, Philip Savage, J Devlin, David F. Griffiths, B. Portman, M. Mason, W. A. Jurewicz

Cael y testun llawn Cael y testun llawn